Summary - A new market study, titled “Global and Japan e-clinical Trials Market Size, Status and Forecast 2020-2026” has been featured on WiseGuyReports.
Global e-clinical Trials Scope and Market Size
e-clinical Trials market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global e-clinical Trials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Clinical Data Management System (CDMS) Solutions
Clinical Trial Management System (CTMS) Solutions
Electronic Clinical Outcomes Assessment (eCOA) Solutions
Randomization and Trial Supply Management (RTSM) Solutions
Other
Market segment by Application, split into
Medical Laboratory
Hospital
Pharmaceutical Company
Other
Based on regional and country-level analysis, the e-clinical Trials market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global e-clinical Trials market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Acceliant
ActiGraph
eClinicalWorks
IntrinsiQ Specialty Solutions
LMK Clinical Research Consulting
Lucidworks
Medrio
Parallel6
Symphony Clinical Research
Perceptive Informatics
EClinical Solutions
Ecrfplus
Clincase
FOR MORE DETAILS: https://www.wiseguyreports.com/reports/5864806-global-and-japan-e-clinical-trials-market-size-status-and-forecast-2020-2026
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +162-825-80070 (US)
Ph: +44 203 500 2763 (UK)
Global e-clinical Trials Scope and Market Sizee-clinical Trials market is segmented by company, region (country), by Type, and by Application.
Players, stakeholders, and other participants in the global e-clinical Trials market will be able to gain the upper hand as they use the report as a powerful resource.
The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/6519425/global-japan-eclinical-trials-2021-2027-49Segment by TypeClinical Data Management System(CDMS) SolutionsClinical Trial Management System(CTMS) SolutionsElectronic Clinical Outcomes Assessment(eCOA) SolutionsRandomization and Trial Supply Management(RTSM) SolutionsOtherSegment by ApplicationMedical LaboratoryHospitalPharmaceutical CompanyOtherBy RegionNorth AmericaU.S.CanadaEuropeGermanyFranceU.K.ItalyRussiaNordicRest of EuropeAsia-PacificChinaJapanSouth KoreaSoutheast AsiaIndiaAustraliaRest of AsiaLatin AmericaMexicoBrazilRest of Latin AmericaMiddle East & AfricaTurkeySaudi ArabiaUAERest of MEABy CompanyAcceliantActiGrapheClinicalWorksIntrinsiQ Specialty SolutionsLMK Clinical Research ConsultingLucidworksMedrioParallel6Symphony Clinical ResearchPerceptive InformaticsEClinical SolutionsEcrfplusClincaseReasons to Purchase Our Research Report:1.
Market dynamics scenario, along with growth opportunities of the market in the years to come3.
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects4.
Regional and country-level analysis integrating the demand and supply forces that are influencing the growth of the market.5.
Growth in this market is driven by the growing pharmaceutical industry in Latin American countries such as Brazil, Mexico, and Argentina; increasing focus of MNCs on investing in the pharmaceutical and healthcare sectors in Latin America; growing pricing pressures; rapid growth in aging population & the subsequent increase in the prevalence of related diseases; and the availability of local and government funding for R activities.The Latin America Pharmaceutical Excipients Market is projected to reach USD 579 million by 2024 from USD 403 million in 2019, at a CAGR of 7.5%.Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=41302221Market Segmentation:- The Latin America pharmaceutical excipients market, by functionality, is segmented into fillers & diluents, binders, suspending & viscosity agents, flavoring agents & sweeteners, coating agents, colorants, disintegrants, lubricants & glidants, preservatives, emulsifiers & solubilizers, and other functionalities.
The fillers & diluents segment accounted for the largest market share in 2018.
The increased use of fillers & diluents in the development and production of solid dosage form and the wide applications of diluents in the wet granulation and direct compression process for tablet formulation are driving the growth of the fillers & diluents segment.Recent Developments:-In 2018, Roquette launched the carbohydrate-based excipients—Maize Starch IP/BP and Mannitol IP.In 2017, DuPont acquired FMC Corporation’s Health & Nutrition business except for the Omega-3 business.
With this acquisition, FMC’s Health & Nutrition segment will be integrated into the DuPont Nutrition & Health segment.
It extends DuPont’s capabilities into the fast-growing pharma excipients space.In 2016, BASF signed an agreement with Colorcon (US) to sell its Kollicoat IR Coating Systems product line to Colorcon.
This enabled the company to focus on its core competencies.
